PHIO 8-K 2026-11-05

Phio Pharmaceuticals Corp. (PHIO) 8-K dated 2026-11-05 — accession 0001437749-26-035277.

Phio Pharmaceuticals Corp. (PHIO) is a biotechnology company listed on US.

Phio Pharmaceuticals Corp. filed a 8-K on 2026-11-05. Accession 0001437749-26-035277.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for PHIO is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The PHIO SEC hub lists recent forms. The stock page is the research view.